5-ASA Suppositories in Hemorrhoidal Disease
Forty patients with active hemorrhoidal disease were entered into this double-blind trial, 20 of whom were randomized to treatment with 5-aminosalicylic acid (5-ASA) (500 mg) suppositories. Clinical and sigmoidoscopic assessment was carried out before the start of the trial and after two weeks of tr...
Saved in:
Main Authors: | P Gionchetti, M Campieri, A Belluzzi, C Brignola, M Miglioli, L Barbara |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1992-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1992/715270 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
by: M. Campieri, et al.
Published: (1989-01-01) -
Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
by: M Campieri, et al.
Published: (1990-01-01) -
Gut Toxicity of 5-ASA?
by: Desmond J Leddin, et al.
Published: (1993-01-01) -
Overview of 5-ASA in Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1994-01-01) -
Exacerbation of Ulcerative Colitis following Administration of 5-ASA Enemas
by: Barbara A. Young, et al.
Published: (1989-01-01)